LITTLE KNOWN FACTS ABOUT HEALTHCARE NEWS.

Britain’s drug regulator permitted the Alzheimer’s drug Kisunla on Wednesday, but The federal government won’t be purchasing it soon after an independent watchdog agency reported the treatment method isn’t worth the Value to taxpayersFifty yrs in the past, Philadelphia prison officials finished a clinical screening application that experien